Effects of Concurrent Training

Not Applicable

• Conditions: sarcopenia.; Muscle loss and atrophy, not elsewhere classified Disuse atrophy NEC, Sarcopenia; M62.5

• Registration Number: IRCT20200126046267N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 33

Inclusion Criteria

Physical Health
At least one year must be passed after Postmenopausal period
Obtain a physical health certificate from a physician
Complete an informed consent form on how to perform the exercises
Lack of exercising in the past six months

Exclusion Criteria

Postmenopausal period Less than a year
Have pain and physical injury
Have heart disease, diabetes, etc.
Take drugs, cigarettes, alcohol

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum Myostatin concentration. Timepoint: Before and after two months of exercise training intervention. Method of measurement: blood sampling from anterior venous arm for use in ELISA Test.;Serum Follistatin concentration. Timepoint: Before and after two months of exercise training intervention. Method of measurement: blood sampling from anterior venous arm for use in ELISA Test.;Upper body strength and endurance. Timepoint: Before and after two months of exercise training intervention. Method of measurement: Count the number of correct performances with device the chest press.;Lower body body strength and endurance. Timepoint: Before and after two months of exercise training intervention. Method of measurement: Counting the number of correct performances lying with the back of the thigh device.